We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The 2025 ADA Standards of Care includes updated ...
LOS ANGELES--(BUSINESS WIRE)--Laekna (2105.HK) announced today that the results of: i) the phase I SAD study of LAE102 (an ActRIIA-selective antibody) for the treatment of obesity; and ii) the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results